Skip to main content

sec filings

Insider trades

Open-market buys and sales that company insiders report to the SEC on .

Side
Planned sales
Role
ADPT

Updated 10/6/2026, 4:41 PM ET.

ADPT

Adaptive Biotechnologies Corp

Sale$1,014,329

RUBINSTEIN JULIE

President and COO

35,643 shat $28.46Filed Oct 5, 8:15 PM ET
Filing
ADPT

Adaptive Biotechnologies Corp

Sale$757,697

LO FRANCIS

Chief People Officer

26,792 shat $28.28Filed Oct 5, 8:12 PM ET
Filing
ADPT

Adaptive Biotechnologies Corp

Sale$3,238,004

LO FRANCIS

Chief People Officer

115,406 shat $28.06Filed Sep 18, 8:17 PM ET
Filing
ADPT

Adaptive Biotechnologies Corp

Sale$32,265

BOBULSKY SUSAN

Chief Commercial Officer, MRD

1,195 shat $27.00Filed Sep 17, 6:50 PM ET
Filing
ADPT

Adaptive Biotechnologies Corp

Sale$249,990

OWEN KATEY EINTERZ

Director

9,615 shat $26.00Filed Aug 28, 5:50 PM ETFiling
ADPT

Adaptive Biotechnologies Corp

Sale$748,208

HERSHBERG ROBERT

Director

30,664 shat $24.40Filed Aug 20, 5:55 PM ETFiling
ADPT

Adaptive Biotechnologies Corp

Sale$14,882,166

ROBINS CHAD M

CEO and Chairman, Director

600,000 shat $24.80Filed Aug 19, 8:15 PM ETFiling
ADPT

Adaptive Biotechnologies Corp

Sale$3,135,850

NEUPERT PETER M

Director

124,690 shat $25.15Filed Aug 19, 8:07 PM ETFiling
ADPT

Adaptive Biotechnologies Corp

Sale$75,000

BOBULSKY SUSAN

Chief Commercial Officer, MRD

3,000 shat $25.00Filed Aug 12, 7:33 PM ET
Filing
ADPT

Adaptive Biotechnologies Corp

Sale$31,176

BOBULSKY SUSAN

Chief Commercial Officer, MRD

1,299 shat $24.00Filed Aug 3, 6:26 PM ET
Filing
ADPT

Adaptive Biotechnologies Corp

Sale$10,780,409

ROBINS HARLAN S

Chief Scientific Officer

492,400 shat $21.89Filed Jul 23, 7:34 PM ET
Filing
ADPT

Adaptive Biotechnologies Corp

Sale$115,000

BOBULSKY SUSAN

Chief Commercial Officer, MRD

5,000 shat $23.00Filed Jul 20, 7:19 PM ET
Filing
ADPT

Adaptive Biotechnologies Corp

Sale$2,389,164

LO FRANCIS

Chief People Officer

105,762 shat $22.59Filed Jul 17, 7:23 PM ET
Filing

Read from public SEC filings. Not financial advice.